Zymeworks
ZYME
14 hedge funds and large institutions have $18M invested in Zymeworks in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
8.63% more ownership
Funds ownership: 0% → 8.63% (+8.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$9.22M |
| 2 |
PA
Perceptive Advisors
New York
|
+$8.18M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$2.6M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.91M |
| 5 |
Millennium Management
New York
|
+$743K |
Top Sellers
ZYME Hedge Fund Activity: Q2 2017 in Review
14 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2017, worth a combined $18M.
Buyers outnumbered sellers: 14 funds opened new ZYME positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $9.22M.
- 14 institutional investors held Zymeworks (ZYME) as of Q2 2017, up from 0 in Q1 2017.
- Funds reported $18M of Zymeworks stock for Q2 2017.
- 14 funds opened new Zymeworks positions in Q2 2017 and 0 closed out, a net change of +14 holders.
- The largest Zymeworks buyer in Q2 2017 was Franklin Resources, an estimated $9.22M added.
Based on aggregated 13F filings for Q2 2017.